Bank Julius Baer & Co
TEVA icon

Bank Julius Baer & Co’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bank Julius Baer & Co’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
+3,236
New +$108K ﹤0.01% 539
2022
Q1 		– Sell
-15,500
Closed -$124K – 791
2021
Q4 		$124K Hold
15,500
– – ﹤0.01% 587
2021
Q3 		$151K Buy
15,500
+45
+0.3% +$421 ﹤0.01% 586
2021
Q2 		$153K Sell
15,455
-45
-0.3% -$476 ﹤0.01% 601
2021
Q1 		$179K Sell
15,500
-3,464
-18% -$39.7K ﹤0.01% 554
2020
Q4 		$183K Buy
18,964
+2,964
+19% +$28.4K ﹤0.01% 591
2020
Q3 		$144K Buy
16,000
+4,000
+33% +$42.3K ﹤0.01% 541
2020
Q2 		$148K Buy
+12,000
New +$136K ﹤0.01% 496

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Bank Julius Baer & Co's TEVA Position: Q2 2026 in Review

Bank Julius Baer & Co opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 3,236 shares worth $110K. The stake represents ﹤0.01% of the portfolio and ranks #539 among its holdings. This is a return to the name: Bank Julius Baer & Co previously reported a position in TEVA as recently as Q4 2021.

Bank Julius Baer & Co first reported a position in TEVA in Q2 2020 and has held it in 8 quarters since. The position peaked at $183K in Q4 2020. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Bank Julius Baer & Co held 3,236 shares of Teva Pharmaceutical Industries Limited worth $110K as of Q2 2026.
  • Teva Pharmaceutical Industries Limited was a new Bank Julius Baer & Co position in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #539 holding.
  • Bank Julius Baer & Co first reported a position in Teva Pharmaceutical Industries Limited in Q2 2020 and has held it in 8 quarters since.
  • Bank Julius Baer & Co's Teva Pharmaceutical Industries Limited position peaked at $183K in Q4 2020.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.